zurück zur Themenseite

Artikel und Hintergründe zum Thema

business development


Cell Analysis

Agilent to Acquire Biotek

Agilent Technologies Inc. (NYSE: A) announced it has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion. With anticipated tax benefits for Agilent, the net purchase price is expected to be approximately $1.05 billion. 


Driving Innovation

Merck Opens Application Phase for Next Accelerator

Merck announced that it has opened the next round of applications for startup companies to participate in the global Merck Accelerator program. Startups can choose to participate in one of the two programs, either at the company’s Innovation Center at global headquarters in Darmstadt or at its China Innovation Hub in Shanghai. Applications for both programs are open from now until August 25, 2019.